Taxifolin Cas:480-18-2

We are Taxifolin CAS:480-18-2 manufacturer and supplier in China, Pls send inquiry of to of visit our official website should you have any interests


4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R-trans)-

Molecular Formula: C15H12O7
Molecular weight:304.25200
Appearance and properties: light yellow powder
Density: 1.702 g/cm3
Boiling point: 687.6ºC
Melting point: 230-233°C (dec.)
Flash point: 264.2ºC
Refractive index: 1.762
Storage conditions: -20ºC Freezer
Vapor pressure: 7.51E-20mmHg at 25°C
Uses: It can inhibit the growth of ovarian cancer cells in a dose-dependent manner. Compared with Qercetin, Douglas fir is not mutagenic and has low toxicity. Douglas fir regulates genes through an ARE-dependent mechanism to play a potential chemopreventive effect.

Items of Analysis Standard of Analysis Test Results
Appearance Light yellow powder Conform
Loss on drying ≤5.0% 0.89%
Ash ≤5.0% 0.10%
Heavy metals Pb ≤0.5ppm Conform
As ≤0.3ppm Conform
Cd ≤0.5ppm Conform
Hg ≤0.1ppm Conform
Microbiological Total Plate Count ≤1000CFU/g Conform
Yeast & Mold ≤100CFU/g Conform
E. Coli ≤3MPN/g ND
Control bacteria /25g Negative ND
Purity (HPLC) ≥98.0% 98.5%
Conclusion Conforms to Factory Standard

Market News:The outlay will be used to grow Takeda’s portfolio of treatments and boost capacity to manufacture additional products for the rare disease community, Stephen Hatke, Takeda’s Thousand Oaks site head, said in a YouTube video about the expansion. The company didn’t name the specific products it plans to make there. Benzonitrile, 4-[2-hydroxy-1-(hydroxymethyl)ethyl]- manufacturer.As for the expansion itself, Takeda will build a new 15,000-square-foot manufacturing facility at the site and expand an existing 14,000-square-feet of production space. Takeda has been knocking around the Thousand Oaks area since 1996, the Business Times said. Cycloheptanecarboxylic acid, 2-(dimethylhydrazono)-, ethyl ester, (Z)- supplier.AstraZeneca’s application for anifrolumab in SLE is under review by regulatory authorities in the US, EU and Japan, with decisions anticipated in the second half of 2021. Anifrolumab is not currently approved in any country. (3-Methylsulfanylcarbonylamino-phenyl)-carbamic acid prop-2-ynyl ester producer.

Related Products
Product Name
2-Chloro-3-fluoro-5-nitropyridine View Details
4-(4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hydrobromide View Details
(R)-(+)-2-(4-Hydroxyphenoxy)propionic acid View Details
O-(2,3,4,5,6-pentafluorophenyl) chloromethanethioate manufacturer 1-(1H-1,3-Benzimidazol-2-yl)-1-ethanone manufacturer 2,6-Dichloroaniline manufacturer 4-Methylthiazole-5-carboxaldehyde manufacturer POTASSIUM TRIOXALATOFERRATE(III) Cas:5936-11-8 manufacturer